0

Sarcopenia Treatment Market Expected to Reach $4,704 Million by 2030

 
2022
Sarcopenia Treatment Market

Report Code : A10526

quote growth of the global sarcopenia treatment market is driven by rise in geriatric population and their adoption of vitamins and dietary supplements for improved treatment of this illness. Furthermore, rise in investments in production of drugs and supplements for the treatment of sarcopenia are expected to boost growth of the sarcopenia treatment market. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, Sarcopenia treatment market by treatment, route of administration, and distribution channel: global opportunity analysis and industry forecast, 2021–2030," The global sarcopenia treatment market size was valued at $2,577 million in 2020, and is projected to reach $4,704 million by 2030, registering a CAGR of 6.1% from 2021 to 2030.

Sarcopenia is a condition characterized by loss of skeletal muscle mass and function. Although it is primarily a disease of the elderly, its development may be associated with conditions that are not exclusively seen in older people. Low muscle mass or gradual loss, overall weakness, and lower stamina are the common symptoms of sarcopenia, which affects physical activity levels. Lower physical activity levels also further contribute to muscle shrinkage.

Major factors that are expected to boost the growth of the sarcopenia treatment market during the forecast period are the rise in incidence of the elderly population and the growing acceptance of vitamins and dietary supplements. Furthermore, increase in cases of sarcopenia is further anticipated to propel the growth of the sarcopenia treatment market. Also, increase in R&D activities for the treatment of sarcopenia is further estimated to boost the growth of the sarcopenia treatment market. In addition, rise in cases of malnutrition because of poor nutritional intake will further provide potential opportunities for the growth of the sarcopenia treatment market in the coming years.

However, rise in price of protein supplement and the inaccessibility of sarcopenia treatment drugs is expected to further challenge the growth of the sarcopenia treatment market in the near future. Furthermore, rise in R&D activities for introduction of novel drugs and advancements in diagnostics technologies to develop superior drug delivery system are anticipated to propel the market for sarcopenia treatment.

Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. Lockdown, government regulations, and continuous increase in infection rate across the country created a widespread financial impact on neurology hospitals and clinics. Large number of hospitals and clinics have witnessed a drop in number of patient visits amid COVID-19 ultimately reducing client contact.

The impact of COVID-19 pandemic is expected to remain positive for the sarcopenia treatment market. As sarcopenia patients are more vulnerable to COVID-19 infection which cause systematic inflammation that results into loss of skeletal muscle. Furthermore, in older persons, the need for social isolation during the COVID-19 pandemic has led to protein deficiency and decrease in daily physical activity which accelerates the loss of muscle strength and function. Persons with diagnosed COVID-19 are also likely to have 2 or 3 weeks of decreased physical functions resulting in secondary sarcopenia which led to increase in demand of protein supplements which promotes the muscle growth. Thus, such factors are having impacted the market growth positively in COVID-19.

The sarcopenia treatment market is segmented into treatment, route of administration, distribution channel, and region.

On the basis of treatment, the market is categorized into vitamin B12 supplement, Vitamin D & Calcium supplement, protein supplements and others. Presently, the protein supplements segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed owing to increase in the prevalence of malnutrition deficiency across the globe, increase in R & D activities for the novel therapies, drugs and supplements are expected to boost growth of the sarcopenia treatment market.

By distribution channel, the market is categorized into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The homecare segment is anticipated to depict significant growth during the forecast period. This is attributed to rise in the incidence of the elderly population and the growing acceptance of vitamins and dietary supplements. Moreover, owing to rapid increase of sarcopenia rate in geriatric population, technological advancements, and lifestyle change drives the growth of the market.

Key Findings Of The Study

  • By treatment, the protein supplement segment witnessed the highest growth with a CAGR of 5.9% in the global sarcopenia treatment market in 2020.
  • By route of administration, the oral segment held the largest market share in 2020 and is expected to remain dominant throughout the forecast period.
  • By distribution channel, the hospital pharmacies segment exhibits the fastest growth and is expected to grow at a CAGR of 5.5% from 2021 to 2030.
  • By region, Asia-Pacific is expected to experience a growth at the highest rate, registering a CAGR of 7.5% during the forecast period.

In 2020, Asia-Pacific dominated the market for sarcopenia treatment and held the largest revenue share in 2020, highest growth rate majorly due to changing lifestyle conditions, increasing geriatric population, and increasing healthcare facilities. Furthermore, increase in R&D activities for development of novel therapies and rise in prevalence of the sarcopenia disease will further boost the growth of the sarcopenia treatment market in the region during the forecast period.

 

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Sarcopenia Treatment Market by Treatment (Protein Supplements, Vitamin B12 Supplements, Vitamin D & Calcium Supplements and Others), Route of Administration (Oral, Parenteral, and Enteral), and Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies: Global Opportunity Analysis and Industry Forecast, 2021-2030 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date May 2024

Luggage Market

Download Sample
rep-img

Published Date May 2024

TEST SFR Market

Download Sample

Buy Full Version
"Sarcopenia Treatment Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers